Improved locomotor recovery after contusive spinal cord injury in Bmal1−/− mice is associated with protection of the blood spinal cord barrier

• Published in: Scientific reports 2020-08, Vol.10 (1), p.14212, Article 14212
• Main Authors: Slomnicki, Lukasz P., Myers, Scott A., Saraswat Ohri, Sujata, Parsh, Molly V., Andres, Kariena R., Chariker, Julia H., Rouchka, Eric C., Whittemore, Scott R., Hetman, Michal
• Format: Article
• Language: English
• Subjects: 631/378/1341; 631/378/1687/1825; 631/378/1689; Animals; ARNTL Transcription Factors - physiology; Arteries; Biodegradability; Blood; Calponin; Compression; Drug delivery; Glycolic acid; Heme; Heme oxygenase (decyclizing); Humanities and Social Sciences; Hyperplasia; Implants; Locomotion; Mechanical properties; Mice, Inbred C57BL; Mice, Knockout; multidisciplinary; Oxidative stress; Oxygenase; Rapamycin; Recovery of Function; Science; Science (multidisciplinary); Spinal Cord Injuries - metabolism; Stents; Substantia alba; Transcriptome; Vascular diseases
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-020-71131-6

The transcription factor BMAL1/ARNTL is a non-redundant component of the clock pathway that regulates circadian oscillations of gene expression. Loss of BMAL1 perturbs organismal homeostasis and usually exacerbates pathological responses to many types of insults by enhancing oxidative stress and inflammation. Surprisingly, we observed improved locomotor recovery and spinal cord white matter sparing in Bmal1 −/− mice after T9 contusive spinal cord injury (SCI). While acute loss of neurons and oligodendrocytes was unaffected, Bmal1 deficiency reduced the chronic loss of oligodendrocytes at the injury epicenter 6 weeks post SCI. At 3 days post-injury (dpi), decreased expression of genes associated with cell proliferation, neuroinflammation and disruption of the blood spinal cord barrier (BSCB) was also observed. Moreover, intraspinal extravasation of fibrinogen and immunoglobulins was decreased acutely at dpi 1 and subacutely at dpi 7. Subacute decrease of hemoglobin deposition was also observed. Finally, subacutely reduced levels of the leukocyte marker CD45 and even greater reduction of the pro-inflammatory macrophage receptor CD36 suggest not only lower numbers of those cells but also their reduced inflammatory potential. These data indicate that Bmal1 deficiency improves SCI outcome, in part by reducing BSCB disruption and hemorrhage decreasing cytotoxic neuroinflammation and attenuating the chronic loss of oligodendrocytes.